Business
Press Release Aug 05 2020
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base)".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 05, 2020, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base)\". View Attachment","length":456,"tagName":"div"}]